BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25793771)

  • 1. High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.
    Andersen V; Vogel LK; Kopp TI; Sæbø M; Nonboe AW; Hamfjord J; Kure EH; Vogel U
    PLoS One; 2015; 10(3):e0119255. PubMed ID: 25793771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
    Kopp TI; Andersen V; Tjonneland A; Vogel U
    Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low ABCB1 gene expression is an early event in colorectal carcinogenesis.
    Andersen V; Vogel U; Godiksen S; Frenzel FB; Sæbø M; Hamfjord J; Kure E; Vogel LK
    PLoS One; 2013; 8(8):e72119. PubMed ID: 23977225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1).
    Englund G; Jacobson A; Rorsman F; Artursson P; Kindmark A; Rönnblom A
    Inflamm Bowel Dis; 2007 Mar; 13(3):291-7. PubMed ID: 17206689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
    Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
    Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513.
    Salphati L; Plise EG; Li G
    Eur J Pharm Sci; 2009 Jun; 37(3-4):463-8. PubMed ID: 19491037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta.
    Neumanova Z; Cerveny L; Ceckova M; Staud F
    AIDS; 2014 Jan; 28(1):9-17. PubMed ID: 24413260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis.
    Campa D; Müller P; Edler L; Knoefel L; Barale R; Heussel CP; Thomas M; Canzian F; Risch A
    Int J Cancer; 2012 Dec; 131(12):2920-8. PubMed ID: 22473764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
    Bruhn O; Cascorbi I
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer.
    To KK; Leung WW; Ng SS
    Exp Cell Res; 2015 Nov; 338(2):222-31. PubMed ID: 26386386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
    Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
    PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.
    Chen M; Xue X; Wang F; An Y; Tang D; Xu Y; Wang H; Yuan Z; Gao W; Wei J; Zhang J; Miao Y
    Oncol Rep; 2012 Jan; 27(1):265-9. PubMed ID: 21956451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y; Miura M; Sunagawa S; Kagaya H; Yasui-Furukori N; Uno T
    Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.
    Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS
    Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
    Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
    Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
    Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
    Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
    Vogel LK; Saebø M; Skjelbred CF; Abell K; Pedersen ED; Vogel U; Kure EH
    BMC Cancer; 2006 Jul; 6():176. PubMed ID: 16820046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
    Campa D; Butterbach K; Slager SL; Skibola CF; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Kaaks R; Boffetta P; Brennan P; Conde L; Bracci PM; Caporaso NE; Strom SS; Camp NJ; Cerhan JR; ; Canzian F; Nieters A
    Int J Cancer; 2012 Aug; 131(4):803-12. PubMed ID: 21918980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.